David K. Meyerholz
About
David K. Meyerholz has authored 260 papers that have received a total of 14.1k indexed citations.
This includes 82 papers in Pulmonary and Respiratory Medicine, 52 papers in Epidemiology and 52 papers in Infectious Diseases. The topics of these papers are SARS-CoV-2 and COVID-19 Research (43 papers), Neonatal Respiratory Health Research (42 papers) and Therapeutic Advances in Cystic Fibrosis Research (36 papers). David K. Meyerholz is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (43 papers), Neonatal Respiratory Health Research (42 papers) and Therapeutic Advances in Cystic Fibrosis Research (36 papers) and collaborates with scholars based in United States, China and Germany. David K. Meyerholz's co-authors include Stanley Perlman, Paul B. McCray, David A. Stoltz, Michael J. Welsh and Mark R. Ackermann and has published in prestigious journals such as Nature, Science and New England Journal of Medicine
In The Last Decade
Explore authors with similar magnitude of impact
Top authors papers by Jeffrey A. Kelly are co-authored with Top fields papers by Erik Næsset are about Top countries impacted by papers by Jay S. Skyler Top authors papers by John R. Graybill are co-authored with Top countries impacted by papers by Brett Kissela Top fields papers by Jan J.G.M. Verschuuren are about Top journals papers by Patrick Gámez are published in Top countries impacted by papers by Gilles Lavigne